Received Oct 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
return of severe shingles pain/severe itching; This non-serious case was reported by a consumer via call center representative and described the occurrence of shingles in a 56-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included shingles (in JAN-2023) and pain (pain that never fully resolved). On 06-AUG-2025, the patient received the 1st dose of Shingrix. In AUG-2025, 2 weeks after receiving Shingrix, the patient experienced shingles (Verbatim: return of severe shingles pain/severe itching). The outcome of the shingles was not resolved. It was unknown if the reporter considered the shingles to be related to Shingrix. It was unknown if the company considered the shingles to be related to Shingrix. Additional Information: GSK Receipt Date:09-OCT-2025 The patient received Shingrix and indicated that prior to receiving the shot she had a case of shingles and experienced pain that never fully resolved, it subsided but did not resolve. But then after receiving the Shingrix shot the severe shingles pain returned and also, she experienced severe itching which has not resolved. She made a comment on Instagram which said went to a new doctor got the Shingrix vaccine. Two weeks later a new case of shingles The batch number was not provided, and will contact the reporter for more information
Medical History/Concurrent Conditions: Pain (pain that never fully resolved); Shingles (in JAN-2023)